Nabriva Therapeutics plc Intangible Assets, Net (Excluding Goodwill)
Nabriva Therapeutics plc had Intangible Assets, Net (Excluding Goodwill) of $1.00 thousand as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2023-10-19
- 2023-06-30: Intangible Assets, Net (Excluding Goodwill) $1.00K.
- 2023-03-31: Intangible Assets, Net (Excluding Goodwill) $2.00K.
- 2022-12-31: Intangible Assets, Net (Excluding Goodwill) $3.00K.
- 2022-09-30: Intangible Assets, Net (Excluding Goodwill) $7.00K.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2023-06-30 | $1.00K 10-Q · filed 2023-10-19 |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $3.00K 10-Q · filed 2023-10-19 |
| 2022-09-30 | $7.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $21.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $31.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $41.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $54.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $65.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $80.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $84.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $97.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $111.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $91.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $343.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $86.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $99.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $98.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $109.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $127.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $155.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $172.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $199.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $211.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $224.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $270.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $3.00K 10-K · filed 2017-03-24 |